ASB Consultores’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

ASB Consultores’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-16,442	Closed	-$1.36M	–	146
2025 Q2	$1.36M	Hold	16,442	–	–	0.91%	19
2025 Q1	$1.33M	Hold	16,442	–	–	0.87%	17
2024 Q4	$1.48M	Hold	16,442	–	–	0.62%	27
2024 Q3	$1.62M	Hold	16,442	–	–	0.64%	24
2024 Q2	$1.52M	Sell	16,442 -8,767	-35%	-$786K	0.55%	22
2024 Q1	$2.39M	Buy	25,209 +8,767	+53%	+$814K	0.62%	22
2023 Q4	$1.47M	Hold	16,442	–	–	0.49%	25
2023 Q3	$1.2M	Buy	16,442 +7,675	+88%	+$613K	0.47%	27
2023 Q2	$729K	Sell	8,767 -7,675	-47%	-$642K	0.35%	53
2023 Q1	$1.25M	Buy	16,442 +9,422	+134%	+$782K	0.5%	29
2022 Q4	$583K	Hold	7,020	–	–	0.24%	52
2022 Q3	$557K	Hold	7,020	–	–	0.26%	47
2022 Q2	$521K	Sell	7,020 -329	-4%	-$24.7K	0.23%	49
2022 Q1	$661K	Hold	7,349	–	–	0.28%	60
2021 Q4	$823K	Buy	+7,349	New	+$886K	0.41%	42

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

ASB Consultores's XBI Position: Q3 2025 in Review

ASB Consultores sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 16,442 shares — an estimated $1.36M sold.

ASB Consultores first reported a position in XBI in Q4 2021 and held it in 15 quarters. The position peaked at $2.39M in Q1 2024. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

ASB Consultores reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
ASB Consultores sold 16,442 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $1.36M.
ASB Consultores first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 15 quarters.
ASB Consultores's State Street SPDR S&P Biotech ETF position peaked at $2.39M in Q1 2024.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on ASB Consultores's 13F filing for Q3 2025, filed 4 Nov 2025.